Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
3.150
+0.050 (1.61%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lipocine Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 17 | 26 | 15 | 35 | 88 | 89 | |
| Market Cap Growth | -31.42% | 75.97% | -57.88% | -59.76% | -2.05% | 547.37% | |
| Enterprise Value | 3 | 6 | -9 | 1 | 52 | 77 | |
| Last Close Price | 3.15 | 4.88 | 2.79 | 6.76 | 16.85 | 23.12 | |
| PE Ratio | - | 3124.75 | - | - | - | - | |
| PS Ratio | 3.91 | 2.33 | -5.20 | 70.42 | 5.42 | - | |
| PB Ratio | 1.21 | 1.24 | 0.73 | 0.99 | 1.92 | 5.82 | |
| P/TBV Ratio | 1.24 | 1.24 | 0.73 | 0.99 | 1.92 | 5.82 | |
| EV/Sales Ratio | 0.58 | 0.57 | - | 2.19 | 3.23 | - | |
| EV/EBITDA Ratio | - | - | - | - | 16.57 | - | |
| EV/EBIT Ratio | - | - | - | - | 16.57 | - | |
| Debt / Equity Ratio | 0.01 | 0.02 | - | - | 0.05 | 0.36 | |
| Debt / EBITDA Ratio | - | - | - | - | 0.73 | - | |
| Asset Turnover | 0.24 | 0.49 | - | 0.01 | 0.42 | - | |
| Quick Ratio | 7.90 | 14.38 | 8.39 | 19.78 | 7.99 | 2.99 | |
| Current Ratio | 8.25 | 14.75 | 8.69 | 20.34 | 8.26 | 3.85 | |
| Return on Equity (ROE) | -32.92% | 0.04% | -58.40% | -26.50% | -2.08% | -193.85% | |
| Return on Assets (ROA) | -21.45% | -3.17% | -37.02% | -16.83% | 5.05% | -49.98% | |
| Return on Capital (ROIC) | -23.50% | -3.45% | -40.02% | -18.14% | 5.71% | -65.45% | |
| Return on Capital Employed (ROCE) | -44.60% | -5.50% | -88.00% | -33.80% | 6.70% | -95.90% | |
| Earnings Yield | -31.31% | 0.03% | -110.25% | -30.56% | -0.73% | -23.47% | |
| FCF Yield | -29.44% | -5.03% | -80.10% | -34.37% | -5.05% | -17.13% | |
| Buyback Yield / Dilution | -0.65% | -2.90% | -0.26% | -1.98% | -57.35% | -115.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.